One Year Follow-up Study: Risperidone and Chlorpromazine for Patients with First-episode Schizophrenia

ZHANG Hongxia,SHEN Xiaoling,ZHANG Huaihui,QIU Hong,JIN Youlan,YANG Xiaomin,JIANG Kaida

DOI: https://doi.org/10.3969/j.issn.1008-6358.2007.06.067

2007-01-01

Abstract:Objective:To compare the efficacy and safety of risperidone and chlorpromazine in treatment of first-episode schizo phrenia.Methods:It is a one year naturalistic study.One hundred and eighty-six patients with first-episode of schizophrenia were included who met ICD-10 criteria for schizophrenia or schizophreniform disorder and received integrated treatment(risper- idone or chlorpromazine plus psychosocial education,family psycho-education).There were 131 patients included in the risperi- done group and 55 included in the chlorpromazine group.Written informed consent was obtained from the patients or their legal guardians.Clinical stains was assessed with the Positive and Negative Symptom Scale(PANSS).the Treatment Emergent Symptom Scale(TESS)and the time to the discontinuation of treatment.The Short Form-36(sf-36)was used to assess the quality of life.Results:Thirty-five percent in the rieperdone group partially completed follow-up assessments and 51% in the chlor promazine group did.the difference of the rates between the two groups was significant.Response rate was defined as improvement in PANSS total score of≥50%.The response rates at the end of 2.3.6.8.12 months in the risperidone group were 29.1%.41.8%. 50.9%.50.9%.56.4% and in the chlorpromazine group were 40.5%.46.6%.57.3%.64.1%.62.6%.respectively.There was no significant difference of the response rate at any of the follow up time between the two groups.The relapse rates were similar as 20. 2% in the risperidone group and 20.6% in the comparing group.The time to the discontinuation of treatment for any cause was longer in the risperidone group than in the chlorpromazine gronp.However.the difference was not significant.Risperidone was associated with lower symptoms of tremor,constipation,sialorrhea(P0.01)and also associated with more frequent reports of agitation,de- pression,insomnia,gastrointestinal disturbance,menstrual disorder(P0.05).There are significant improvements in 6 factors (role of physics,body pain.globe health,social function,role of emotion and mental heahh)of sf 36 in risperidone group and only 2 factory(social function,role of emotion)in the comparative group.Conclusion:The efficacy of risperidone is as same as that of chlorpromazine in the treatment of first-episode schizophrenia,yet the rates of some adverse events are different in the two groups and risperidone may enhance the quality of life from more aspects.